AI assistant
Sending…
BRADY CORP — Director's Dealing 2017
Nov 28, 2017
31233_dirs_2017-11-28_26be85a1-5260-4d9d-9ba4-020bdb87add9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BRADY CORP (BRC)
CIK: 0000746598
Period of Report: 2017-11-27
Reporting Person: Thornton Ann (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-27 | Class A Common Stock | M | 1129 | $27.28 | Acquired | 10349 | Direct |
| 2017-11-27 | Class A Common Stock | F | 953 | $39 | Disposed | 9396 | Direct |
| 2017-11-27 | Class A Common Stock | M | 3198 | $19.96 | Acquired | 12594 | Direct |
| 2017-11-27 | Class A Common Stock | F | 2390 | $39 | Disposed | 10204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-27 | Stock Option Net Exercise | $27.28 | M | 1129 | Disposed | 2024-12-31 | Class A Common Stock (1129.0) | Direct |
| 2017-11-27 | Stock Option Net Exercise | $19.96 | M | 3198 | Disposed | 2025-09-25 | Class A Common Stock (3198.0) | Direct |
Footnotes
F1: Represents net exercise of stock option. 1,129 options were exercised, resulting in a net gain of 176 shares (340 gross shares less payroll tax withholding of 164 shares).
F2: Represents net exercise of stock option. 3,198 options were exercised, resulting in a net gain of 808 shares (1,561 gross shares less payroll tax withholding of 753 shares).
F3: Represents options exercisable one third each year for the three years subsequent to the grant date.
More from BRADY CORP
Interim / Quarterly Report
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 20
Interim / Quarterly Report
2026
Feb 19
Regulatory Filings
2026
Feb 19